Asthma
Conditions
Interventions
Control group:Conventional drug therapy
Treatment group:Pediatric asthma oral solution Conventional drug therapy
Sponsors
the Children’s Hospital of Zhejiang University School of Medicine
Eligibility
Sex/Gender
All
Age
6 Years to 13 Years
Inclusion criteria
Inclusion criteria: 1. Meet the diagnostic criteria defined in GINA (2025) and the Guidelines for the Diagnosis and Prevention of Bronchial Asthma in Children; 2. Meet the TCM syndrome differentiation criteria for febrile asthma syndrome; 3. Those with asthma exacerbation severity graded as mild; 4. Age 6~13 years old (= 8 years old) jointly signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Children with bronchial asthma in the critical stage, or those with fever within <=48h at the time of screening, as well as complicated by laryngitis, pneumonia, sepsis and other diseases; 2. Children with other diseases that can cause asthma or dyspnea, children with tuberculosis, pulmonary interstitial fibrosis, bronchiectasis, thoracic deformity and other diseases; 3. Children with severe malnutrition, rickets and serious primary diseases such as heart, brain, liver, kidney, hematopoietic system, psychiatry, and nervous system; 4. Those who had respiratory tract infection within 6 weeks before selection; 5. Those whose asthma exacerbation severity is graded as severe; 6. Those who are allergic to the test drug or have relevant drug contraindications; 7. Children who participated in other clinical trials within 1 month; 8. Those who are considered by the investigator to be inappropriate to participate in this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical improvement rate; | — |
Countries
China
Contacts
Public ContactLanfang Tang
the Children’s Hospital of Zhejiang University School of Medicine
Outcome results
None listed